Share Print Page

Patents

Related Services

Hot Topics

 

PATENTS

Protecting innovation is critical for those seeking to maximize the potential of new products and processes. At Nixon Peabody, we help businesses safeguard their innovations through patents. Our Patents practice assists clients in maximizing the revenue generated by their products and processes by providing a full range of services related to patent procurement. Since 2010, the efforts of Nixon Peabody’s patent practice have resulted in the issuance of more than 2,100 patents and the filing of 4,420 new patent applications in the United States.

Patent procurement services

  • Strategic portfolio management
  • Preparing and prosecuting patent applications, both in the United States and internationally
  • Conducting patentability and validity studies
  • Correcting errors in issued patents
  • Conducting patent interference proceedings and new post grant actions before the U.S. Patent and Trademark Office
  • Preparing infringement analysis and opinions
  • Licensing and assignments

Experienced attorneys

As one of the leading patent procurement law firms in the U.S., Nixon Peabody has a wealth of knowledge and experience working with the U.S. Patent and Trademark Office (USPTO). Our patent prosecution attorneys are among the most experienced in handling interference procedures, the current inter partes procedure used in the USPTO to determine priority among competing applications to patent the same invention. Our attorneys also have substantial experience in prosecuting reissue applications and reexaminations of issued United States patents. Our attorneys are at the forefront of patent reform—monitoring changes and preparing our clients for how the America Invents Act will impact their patent strategy.

The hands-on patent experience of our attorneys and agents is complemented by their rich technical educations and industry experience in a variety of engineering fields, including:

  • Electronics
  • Electromechanical
  • Biotechnology
  • Life sciences
  • Chemistry
  • Computer software
  • Mechanics

Worldwide patent protection

We regularly act as U.S. counsel in intellectual property matters for companies in Europe, Asia, North America, and South America. Nixon Peabody’s international intellectual property team has established personal, longstanding relationships with companies and attorneys throughout the world, particularly in Japan, Korea, China, Hong Kong, Singapore, Australia, Canada, India, the United Kingdom, Spain, and Germany, that help them understand the different local economic and legal motivations driving companies in each of these jurisdictions. We also help U.S. companies secure intellectual property rights abroad through a well-established, worldwide network of legal experts.

    Representative Experience

    • Assist a major software company in protecting its breakthrough advances in the areas of science and engineering and successfully defended the company against three reexamination attempts by third parties
      Assist a major software company in protecting its breakthrough advances in the areas of science and engineering and successfully defended the company against three reexamination attempts by third parties
    • Manage a portfolio of U.S. and international patents on behalf of one the largest companies in the computer entertainment and video game industry  
      Manage a portfolio of U.S. and international patents on behalf of one the largest companies in the computer entertainment and video game industry
    • Conduct IP due diligence on behalf of a large semiconductor company related to potential acquisition targets
      Conduct IP due diligence on behalf of a large semiconductor company related to potential acquisition targets
    • . . . View all . . .
    • Advise a leading currency authentication company with respect to managing a wide portfolio of U.S. and foreign patent
      Advise a leading currency authentication company with respect to managing a wide portfolio of U.S. and foreign patent
    • Represent a large media company in various IP transactions, including licensing arrangements
      Represent a large media company in various IP transactions, including licensing arrangements
    • Handle technology transfer and licensing work on behalf of a leading academic medical center
      Handle technology transfer and licensing work on behalf of a leading academic medical center
    • Represent one of the world’s most recognized energy companies in a variety of licensing transactions, as well as a joint venture
      Represent one of the world’s most recognized energy companies in a variety of licensing transactions, as well as a joint venture
    • Conduct IP due diligence on behalf of a financial service firm related to its investment in a third party
      Conduct IP due diligence on behalf of a financial service firm related to its investment in a third party
    • Work with one of the leading academic institutions in the United States to develop and execute an overall patent strategy for a water purification technology; this technology is particularly promising for under-developed countries
      Work with one of the leading academic institutions in the United States to develop and execute an overall patent strategy for a water purification technology; this technology is particularly promising for under-developed countries
    • Provide U.S. and international patent prosecution services to one of the leading global manufacturers of conveyor belts for food processing and other applications
      Provide U.S. and international patent prosecution services to one of the leading global manufacturers of conveyor belts for food processing and other applications
    • Assist a cutting-edge stem cell institute in devising and executing strategies that will extract the greatest value from their IP and also assist the institute in maneuvering around other people’s patents
      Assist a cutting-edge stem cell institute in devising and executing strategies that will extract the greatest value from their IP and also assist the institute in maneuvering around other people’s patents
    • Manage an extensive patent portfolio on behalf of one of the leading wireless telecommunications companies
      Manage an extensive patent portfolio on behalf of one of the leading wireless telecommunications companies
    • Manage a large U.S. patent portfolio for a  Japanese research and development company focused on semiconductor and flat panel displays; the work we do is critical to the company’s success since its revenue model is predicated on its R&
      Manage a large U.S. patent portfolio for a  Japanese research and development company focused on semiconductor and flat panel displays; the work we do is critical to the company’s success since its revenue model is predicated on its R&D
    . . . Hide Representative Experience . . .

    Thought Leadership/Alerts

    Personalized Medicine Patent Watch
    Intellectual Property Alert | October 31, 2012

    Federal circuit holds an assertion of induced infringement does not require proof of underlying direct infringement by a single party
    Intellectual Property Alert | September 10, 2012

    . . . View all . . .

    The developing legacy of Prometheus: new interim guidelines for patent eligible subject matter
    Intellectual Property Alert | July 16, 2012

    How abstract is too abstract for a patent?
    Intellectual Property Alert | July 10, 2012

    Personalized Medicine Patent Watch Update
    Intellectual Property Alert | July 9, 2012

    Federal Circuit holds the objective prong of the willful infringement analysis is a question of law to be reviewed de novo
    Intellectual Property Alert | June 26, 2012

    Webinar Recording: Marketing Your Products and Services Without Losing Your IP
    Originally recorded June 14, 2012 | June 19, 2012

    Supreme Court unanimously holds § 145 to allow admission of new evidence and de novo review of BPAI decisions by the District of Columbia
    Intellectual Property Alert | April 23, 2012

    Webinar Recording: Surviving Mayo v. Prometheus
    Originally recorded April 10, 2012 | April 11, 2012

    Divided en banc Federal Circuit: only new or amended claims in reexamination give rise to intervening rights
    Intellectual Property Alert | March 19, 2012

    Federal Circuit holds res judicata bars new action after reexam, but not infringing actions or device modifications occurring after the previous complaint
    Intellectual Property Alert | March 16, 2012

    ‘First-to-File' is a year away, but planning should start today
    Intellectual Property Alert | March 14, 2012

    Federal Circuit avoids "murky morass" of Section 101 jurisprudence, proceeds directly to Sections 102 and 103
    Intellectual Property Alert | March 7, 2012

    Crafting personalized medicine IP protection—walking the thin line between patent eligibility and enforcement
    Intellectual Property Alert | January 10, 2012

    USPTO announces: fast-track patent processing available after the filing of an RCE
    Intellectual Property Alert | December 21, 2011

    Federal Circuit grants mandamus, transfers patent case against Delaware company out of Delaware
    Intellectual Property Alert | December 9, 2011

    Webinar Recording: Top 5 Things You Need to Know about Patent Reform
    September 30, 2011

    Joint Infringement—Potential Defense Available to Companies Accused of Patent Infringement
    Intellectual Property Alert | September 23, 2011

    Patent Reform Primer: Changes to the Grace Period
    Intellectual Property Alert | September 15, 2011

    Federal Circuit reduces patentable subject matter for insurance industry patents
    Intellectual Property Alert | September 14, 2011

    Ninth Circuit clarifies jurisdiction rules in intellectual property cases brought against out-of-state companies operating on the Internet
    Intellectual Property Alert | August 16, 2011

    Seeing red: NY court refuses to enforce single color trademark for shoe design
    Intellectual Property Alert | August 15, 2011

    Preamble Defines Field of Invention in Foreseeable Alternative Analysis
    August 15, 2011

    First Induced Pluripotent Stem Cell (iPSC) Patent Approved by the EPO
    Intellectual Property Alert | August 2, 2011

    Federal Circuit issues opinion in ACLU v. Myriad
    Intellectual Property Alert | July 29, 2011

    Patent reform primer
    Changes to the grace period

    Intellectual Property Alert | July 14, 2011

    Eeny, Meeny, Miny, MOVE!—Taking the Guess Work Out of Selecting from the Plethora of Accelerated Patent Prosecution Options
    July 1, 2011

    New .XXX domain name tentatively scheduled to launch September 7, 2011 — clients are advised they may be able to block certain domains to prevent future use
    Intellectual Property Alert | June 21, 2011

    U.S. PTO Restriction Practice: Personalized medicine claims with SNPs
    Intellectual Property Alert | June 13, 2011

    Employers (particularly universities): check your invention assignment agreements!
    Intellectual Property Alert | June 7, 2011

    Webinar Recording: 2011: The Stem Cell Odyssey Continues
    June 3, 2011

    Therasense decision highlights specific intent requirement for inequitable conduct determinations
    Intellectual Property Alert | June 1, 2011

    Follow-on Biologics legislation has immediate impact on patent holders
    Intellectual Property Alert | May 25, 2011

    Protecting personalized medicine innovation in China and India: Are diagnostic methods patentable?
    Intellectual Property Alert | May 17, 2011

    A patent in 12 months? But it will cost you!
    Intellectual Property Alert | April 6, 2011

    Federal Circuit hears oral argument on Myriad ”gene patents”
    Intellectual Property Alert | April 4, 2011

    The Federal Circuit holds that the heightened pleading standards of Rule 9(b) apply to false patent marking claims, finding general allegations of “sophistication” and “knowledge” to be insufficient to state a claim under Section 292
    Intellectual Property Alert | March 15, 2011

    Restrictions on the beneficial use of software
    Intellectual Property Alert | November 16, 2010

    In Stauffer decision, Federal Circuit finds that qui tam relator has standing to pursue false marking claims under Patent Act
    Intellectual Property Alert | August 31, 2010

    Webinar Recording: Bilski v. Kappos: What Does it Mean for Biotech?
    July 22, 2010

    According to the Patent Office, the machine-or-transformation test is alive and well
    Intellectual Property Alert | July 2, 2010

    Supreme Court affirms Federal Circuit’s judgment that risk hedging claims not patent eligible; rejects “machine-or-transformation” test as sole test of patent eligibility of process claims
    Intellectual Property Alert | June 28, 2010

    In Solo Cup decision, Federal Circuit affirms district court’s ruling on burden of proof for intent to deceive and false marking with expired patents, and confirms the definition of “offenses”
    Intellectual Property Alert | June 11, 2010

    . . . Hide Thought Leadership. . .

    Press

    Media Clips

    • Attorneys, Tech Transfer Pros Offer Their Take on How to Address New Rules under AIA
      Technology Transfer Tactics | March 1, 2013

      Boston partner and Patents practice co-leader Ron Eisenstein discusses new key provisions of the America Invents Act (AIA).

    • Top 40 Angelenos to Know in Intellectual Property Law
      Los Angeles Business Journal | October 29, 2012

      Los Angeles Patents partner Seth Levy is profiled in this special section highlighting “Who’s Who” in intellectual property in the region.

    • EXTRA! EXTRA! En Banc Federal Circuit Overrules Its Precedent on Induced Infringement
      IP Today | October 16, 2012

      Authored by Chicago intellectual property partner Paul Kitch and Chicago intellectual property litigation associate Jason Kunze, this article discusses the law concerning induced infringement of patented methods. Click here to download the article.

    • . . . View all . . .
    • Federal Circuit Again Upholds Myriad's BRCA Gene Claims
      BioWorld Today | August 17, 2012

      Washington, DC, Patents counsel Mary Webster provides commentary in this article focused on the decision by the U.S. Court of Appeals for the Federal Circuit regarding the validity of Myriad Genetics Inc.’s claims for its BRACAnalysis breast cancer gene test.

    • Washington Roundup: Federal Circuit Broadens Hatch-Waxman Safe Harbor
      BioWorld Today | August 7, 2012

      This article recaps a recent U.S. Court of Appeals decision expanding the safe harbor for generic drug makers. Washington, DC, patents counsel Mary Webster is quoted discussing how expanding the safe harbor will affect patent claims.

    • Federal Circuit Revisits Myriad Breast Cancer Gene Claims
      BioWorld Today | July 23, 2012

      This article focuses on the Association for Molecular Pathology v. Myriad Genetics Inc. case and arguments in the Federal Circuit about the patentability of isolated DNA. Washington, DC, Patents counsel Mary Webster provides commentary.

    • Business of Law: Nixon Peabody Expands IP Practice in L.A. with Davis Wright Team
      Bloomberg News | May 8, 2012

      This article highlights the arrival of Los Angeles Patents and Life Sciences partner Seth Levy and his team.

    • Nixon Peabody LLP Meets KenJiva’s IP Challenge
      The Law Project | April 12, 2012

      Chicago Patents counsel Wayne Tang is featured in this story discussing an intellectual property matter faced by the CEO of KenJiva Energy Systems, a startup energy management firm. Wayne provided legal counsel pro bono through the organization the Law Project.

    • Fallout from Court Decision to Have Long-Term Impact
      BioWorld Today | March 21, 2012

      This article focuses on the Supreme Court ruling determining that Prometheus Laboratories Inc.’s process claims were not patent eligible. Boston partner and co-leader of the firm’s Patents practice group Ron Eisenstein provides third-party commentary about what the ruling means for the biopharma industry and personalized medicine.

    • Start-Up Biotechs May Face Rock-Hard Patent Quandary
      BioWorld Today | March 12, 2012

      This article notes that small biotechs, universities, and other holders of early upstream patents could find themselves caught between the new first-to-file patent system and the ever tougher patent standard being set by the Court of Appeals for the Federal Circuit. Washington, DC, Patents counsel Mary Webster provides commentary.

    • Increased Biopharma Patent Valuation Fuels Litigation
      BioWorld Insight | January 30, 2012

      This article notes that as patents are becoming increasing more important for biopharma organizations, patent litigation is also increasing and raising the patents’ values at the same time. Washington, DC, Patents counsel Mary Webster provides commentary.

    • TTOs Often Walk a Fine Line When Negotiating Rights to Improvements
      Technology Transfer Tactics | January 1, 2012

      This feature story discusses how technology transfer offices (TTOs) can effectively deal with the rights to intellectual property improvements in license agreements. Boston partner and co-leader of the firm’s Patents practice Ron Eisenstein provides commentary in the piece.

    • Personalized Medicine Could Hinge on Supreme Court Ruling
      BioWorld Today | December 8, 2011

      This story notes that the future of personalized medicine rests in the hands of the U.S. Supreme Court as it mulls arguments in Mayo Collaborative Services v. Prometheus Laboratories Inc. Patents practice co-leader and member of the firm’s Life Sciences practice David Resnick provides third-party commentary.

    • What TTOs Need to Know about Freedom-to-operate Analyses
      Technology Transfer Tactics | December 1, 2011

      Boston partner and co-leader of the firm’s Patents practice Ron Eisenstein provides commentary in this article abut what Technology Transfer Office (TTO) managers need to know about freedom to operate investigations.

    • Search is on for Incentives to Spark Pediatric Drug R&D
      BioWorld Financial Watch | October 17, 2011

      This article discusses what is needed to increase development of drugs and biologics to treat rare pediatric diseases. Washington, DC, Patents counsel Mary Webster provides commentary.

    • Reform Review: IP lawyers say concerns run high among clients
      Boston Business Journal | September 30, 2011

      Featured within the publication’s special “IP Law” section, this article discusses the long awaited patent reform. Boston partner and co-leader of the patents practice Ron Eisenstein provides commentary.

    • Developments in Joint Infringement Law
      Law 360 | September 28, 2011

      This article, co-authored by Chicago patents partner Paul Kitch and Chicago Intellectual Property Litigation associate Jason Kunze, discusses the need for companies to be aware of the potential defenses available if accused of patent infringement.

    • People on the Move
      Boston Business Journal | September 27, 2011

      This coverage notes that patents practice co-leader and member of the firm’s life sciences practice David Resnick has been named a member of the Personalized Medicine Coalition’s Public Policy Committee.

    • Federal Circuit Decides Human Genes Patentable
      Massachusetts Lawyers Weekly | September 14, 2011

      This feature article discusses the U.S. Court of Appeals ruling finding that human genes are patentable. Patents practice co-leader and member of the life sciences practice David Resnick provides third-party commentary.

    • Biotech Sizes Up Federal Circuit Ruling in Myriad Case
      BioWorld Today | August 2, 2011

      This feature article discusses the U.S. Court of Appeals for the Federal Circuit ruling finding that isolated DNA and complementary DNA (cDNA) can be patented, but striking down method claims for a process that compares and analyzes nucleotide sequences because the method did not involve a “transformative” step. Washington, DC, patents counsel Mary Webster provides commentary.

    . . . Hide Media Clips . . .

    Events

    Patents